BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 24643649)

  • 1. Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.
    Hawk ET; Habermann EB; Ford JG; Wenzel JA; Brahmer JR; Chen MS; Jones LA; Hurd TC; Rogers LM; Nguyen LH; Ahluwalia JS; Fouad M; Vickers SM
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1113-21. PubMed ID: 24643649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
    Chen MS; Lara PN; Dang JH; Paterniti DA; Kelly K
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1091-6. PubMed ID: 24643646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).
    Durant RW; Wenzel JA; Scarinci IC; Paterniti DA; Fouad MN; Hurd TC; Martin MY
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1097-105. PubMed ID: 24643647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual.
    Vickers SM; Fouad MN
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1087-90. PubMed ID: 24643645
    [No Abstract]   [Full Text] [Related]  

  • 5. A primer for cancer research programs on defining and evaluating the catchment area and evaluating minority clinical trials recruitment.
    Nguyen LH; Cook ED
    Adv Cancer Res; 2020; 146():219-226. PubMed ID: 32241390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.
    Barrett NJ; Rodriguez EM; Iachan R; Hyslop T; Ingraham KL; Le GM; Martin K; Haring RC; Rivadeneira NA; Erwin DO; Fish LJ; Middleton D; Hiatt RA; Patierno SR; Sarkar U; Gage-Bouchard EA
    Cancer; 2020 Mar; 126(5):1077-1089. PubMed ID: 31909824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the health belief model to assess racial/ethnic disparities in cancer-related behaviors in an NCI-designated comprehensive cancer center catchment area.
    Otto AK; Ketcher D; McCormick R; Davis JL; McIntyre MR; Liao Y; Reblin M; Vadaparampil ST
    Cancer Causes Control; 2021 Oct; 32(10):1085-1094. PubMed ID: 34132914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What factors influence minority use of National Cancer Institute-designated cancer centers?
    Huang LC; Ma Y; Ngo JV; Rhoads KF
    Cancer; 2014 Feb; 120(3):399-407. PubMed ID: 24452674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic proximity and racial disparities in cancer clinical trial participation.
    Kanarek NF; Tsai HL; Metzger-Gaud S; Damron D; Guseynova A; Klamerus JF; Rudin CM
    J Natl Compr Canc Netw; 2010 Dec; 8(12):1343-51. PubMed ID: 21147901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
    Mishkin G; Minasian LM; Kohn EC; Noone AM; Temkin SM
    Gynecol Oncol; 2016 Dec; 143(3):611-616. PubMed ID: 27697287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    Murthy VH; Krumholz HM; Gross CP
    JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Center Testing for SARS-CoV-2 During the COVID-19 Pandemic - United States, June 5-October 2, 2020.
    Romero L; Pao LZ; Clark H; Riley C; Merali S; Park M; Eggers C; Campbell S; Bui C; Bolton J; Le X; Fanfair RN; Rose M; Hinckley A; Siza C
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1895-1901. PubMed ID: 33332299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Geographic Accessibility of National Cancer Institute Cancer Centers in the United States.
    Xu Y; Fu C; Onega T; Shi X; Wang F
    J Med Syst; 2017 Nov; 41(12):203. PubMed ID: 29128881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrollment and Racial Disparities in Cancer Treatment Clinical Trials in North Carolina.
    Zullig LL; Fortune-Britt AG; Rao S; Tyree SD; Godley PA; Carpenter WR
    N C Med J; 2016; 77(1):52-8. PubMed ID: 26763244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An institutional strategy to increase minority recruitment to therapeutic trials.
    Anwuri VV; Hall LE; Mathews K; Springer BC; Tappenden JR; Farria DM; Jackson S; Goodman MS; Eberlein TJ; Colditz GA
    Cancer Causes Control; 2013 Oct; 24(10):1797-809. PubMed ID: 23846282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Institute of Medicine report "Unequal Treatment": implications for academic health centers.
    Betancourt JR; Maina AW
    Mt Sinai J Med; 2004 Oct; 71(5):314-21. PubMed ID: 15543432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial, Ethnic, and Gender Representation in Leadership Positions at National Cancer Institute-Designated Cancer Centers.
    Morgan A; Shah K; Tran K; Chino F
    JAMA Netw Open; 2021 Jun; 4(6):e2112807. PubMed ID: 34097046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A National Map of NCI-Designated Cancer Center Catchment Areas on the 50th Anniversary of the Cancer Centers Program.
    DelNero PF; Buller ID; Jones RR; Tatalovich Z; Vanderpool RC; Ciolino HP; Croyle RT
    Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):965-971. PubMed ID: 35101903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equal participation of minority patients in U.S. national pediatric cancer clinical trials.
    Bleyer WA; Tejeda HA; Murphy SB; Brawley OW; Smith MA; Ungerleider RS
    J Pediatr Hematol Oncol; 1997; 19(5):423-7. PubMed ID: 9329463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.